160 related articles for article (PubMed ID: 24658180)
1. Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan.
Nabae K; Satoh H; Nishiura H; Tanaka-Taya K; Okabe N; Oishi K; Matsumoto K; Hasegawa T
PLoS One; 2014; 9(3):e92519. PubMed ID: 24658180
[TBL] [Abstract][Full Text] [Related]
2. Serologic study of human parvovirus B19 infection in pregnancy in Japan.
Yaegashi N; Niinuma T; Chisaka H; Uehara S; Okamura K; Shinkawa O; Tsunoda A; Moffatt S; Sugamura K; Yajima A
J Infect; 1999 Jan; 38(1):30-5. PubMed ID: 10090504
[TBL] [Abstract][Full Text] [Related]
3. [Anti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro].
da Silva AR; Nogueira SA; Alzeguir JC; da Costa MC; do Nascimento JP
Rev Soc Bras Med Trop; 2006; 39(5):467-72. PubMed ID: 17160325
[TBL] [Abstract][Full Text] [Related]
4. High rate of severe fetal outcomes associated with maternal parvovirus b19 infection in pregnancy.
Beigi RH; Wiesenfeld HC; Landers DV; Simhan HN
Infect Dis Obstet Gynecol; 2008; 2008():524601. PubMed ID: 18464909
[TBL] [Abstract][Full Text] [Related]
5. Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection.
Enders M; Klingel K; Weidner A; Baisch C; Kandolf R; Schalasta G; Enders G
J Clin Virol; 2010 Nov; 49(3):163-8. PubMed ID: 20729141
[TBL] [Abstract][Full Text] [Related]
6. The burden of parvovirus B19 infection in women of childbearing age in England and Wales.
Vyse AJ; Andrews NJ; Hesketh LM; Pebody R
Epidemiol Infect; 2007 Nov; 135(8):1354-62. PubMed ID: 17291377
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of parvovirus B19 specific antibody in pregnant women with spontaneous abortion.
Rahbar N; Vali Zadeh S; Ghorbani R; Kheradmand P
Acta Med Iran; 2015; 53(3):168-72. PubMed ID: 25796023
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
Elnifro E; Nisha AK; Almabsoot M; Daeki A; Mujber N; Muscat J
J Infect Dev Ctries; 2009 Apr; 3(3):218-20. PubMed ID: 19759477
[TBL] [Abstract][Full Text] [Related]
9. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
Alsamarai AM; Hassan HM; Alsamarai MA; Aljumaili ZK
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):359-366. PubMed ID: 34315400
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
Maksheed M; Pacsa AS; Essa SS; Ahmed MA; Monem RA; Surkouh M
Acta Trop; 1999 Oct; 73(3):225-9. PubMed ID: 10546839
[TBL] [Abstract][Full Text] [Related]
12. Risk of perinatal transmission of rubella and parvovirus B19 in Jordanian pregnant women.
Bdour S
Vaccine; 2006 Apr; 24(16):3309-12. PubMed ID: 16460842
[TBL] [Abstract][Full Text] [Related]
13. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
Enders M; Weidner A; Zoellner I; Searle K; Enders G
Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
[TBL] [Abstract][Full Text] [Related]
14. [The frequency of human parvovirus B19 infections in Vojvodina].
Milosević V; Jerant-Patić V; Hrnjaković-Cvjetković I; Vukmanović-Papuga M; Jelena RT; Kovacević G
Med Pregl; 2007; 60(11-12):575-9. PubMed ID: 18666599
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.
Mossong J; Hens N; Friederichs V; Davidkin I; Broman M; Litwinska B; Siennicka J; Trzcinska A; VAN Damme P; Beutels P; Vyse A; Shkedy Z; Aerts M; Massari M; Gabutti G
Epidemiol Infect; 2008 Aug; 136(8):1059-68. PubMed ID: 17956642
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV/AIDS at the Kitwe Central Hospital, blood bank.
Chirambo-Kalolekesha M; Kaile T; Mwaba F; Daka V; Simakando M; Kowa S
Afr Health Sci; 2018 Sep; 18(3):496-502. PubMed ID: 30602980
[TBL] [Abstract][Full Text] [Related]
18. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran.
Ziyaeyan M; Rasouli M; Alborzi A
Jpn J Infect Dis; 2005 Apr; 58(2):95-7. PubMed ID: 15858287
[TBL] [Abstract][Full Text] [Related]
19. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria.
Emiasegen SE; Nimzing L; Adoga MP; Ohagenyi AY; Lekan R
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):227-31. PubMed ID: 21537685
[TBL] [Abstract][Full Text] [Related]
20. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis.
Nunoue T; Kusuhara K; Hara T
Pediatr Infect Dis J; 2002 Dec; 21(12):1133-6. PubMed ID: 12488663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
